106P Longitudinal Molecular Characterization in Plasma of EGFR Mutant Non-Small Cell Lung Cancer (NSCLC) Experiencing Early Progression (EPD) on First-Line Osimertinib (Osi)
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined